Comparison
Relevia and Pain & Inflammation Blend
Relevia (NewtonEverett) lists 9 distinct ingredients and Pain & Inflammation Blend (Innerzyme) 7 (rows of one ingredient counted once); 7 are on both labels. On the site's similarity measure, which compares ingredient lists (1 for the same list, rarer ingredients counting for more; amounts are not part of it), the two formulas score 0.87.
| Ingredient | Relevia | Pain & Inflammation Blend |
|---|---|---|
| Turmeric | 100 mg | 100 mg |
| Bromelain | not disclosed | 720 GDU |
| Papain | not disclosed | 6,000,000 USP |
| Rutin | 400 mg | 400 mg |
| White Willow | 100 mg | 100 mg |
| Trypsin | not disclosed | 9,000 USP |
| Chymotrypsin | not disclosed | 250 USP |
| Calcium | 382 mg (29%) | |
| Phosphorus | 299 mg (24%) |
Amounts are per serving as DSLD gives them: Relevia, 4 tablets; Pain & Inflammation Blend, 4 tablets. Current labels entered May 2021 and September 2015. Percentages of the Daily Value from 21 CFR 101.9. Source: NIH ODS Dietary Supplement Label Database.
Each product on its own
- ReleviaNewtonEverett: every row against all products listing it
- Pain & Inflammation BlendInnerzyme: every row against all products listing it